Patent Assignment
Reel/Frame 063931/0392
Merger
Recorded: 2023-06-13
Pages: 10
Assignor
OPIANT PHARMACEUTICALS, INC.
Executed: 2023-05-25
Assignee
INDIVIOR INC.
10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VIRGINIA, 23235
Covered Properties
(6)
Compositions and Methods for the Treatment of Opioid Overdose
Patent:
11,458,091 →
Application:
16/461,354 →
Publication:
US 2020/0060967
PCT:
PCT/US2022/039463 ↗
Formulations and Methods for the Prevention of Opioid Overdose
Application:
17/055,647 →
Publication:
US 2021/0220346
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
17/291,979 →
Publication:
US 2021/0401827
Compositions and Methods for the Treatment of Opioid Overdose
Application:
17/881,191 →
Publication:
US 2022/0387306
Compositions and Methods for the Treatment of Opioid Overdose
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
18/174,858 →
Publication:
US 2023/0225961
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 7, 2019
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050642/0976 →
Assignment of Assignor's Interest
Oct 7, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050639/0392 →
Assignment of Assignor's Interest
Oct 7, 2019
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050639/0758 →
Assignment of Assignor's Interest
Oct 7, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050642/0358 →
Assignment of Assignor's Interest
Jan 14, 2021
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054915/0020 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS LLC
Reel/Frame 054915/0209 →
Assignment of Assignor's Interest
Jan 14, 2021
From: SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 054915/0123 →
Assignment of Assignor's Interest
May 6, 2021
From: CRYSTAL, ROGER; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 056164/0149 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Assignment of Assignor's Interest
Aug 4, 2022
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 060723/0089 →
Assignment of Assignor's Interest
Aug 4, 2022
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 060723/0046 →
Security Interest
Jun 4, 2023
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 063848/0209 →
Assignment of Assignor's Interest
Apr 4, 2024
From: SKOLNICK, PHIL; ELLISON, MARK; CRYSTAL, ROGER
To: INDIVIOR INC.
Reel/Frame 067003/0973 →
Corrective Assignment to Correct the the City of the Assignee Previously Recorded at Reel: 67003 Frame: 973. Assignor(S) Hereby Confirms the Assignment.
Aug 28, 2024
From: SKOLNICK, PHIL; ELLISON, MARK; CRYSTAL, ROGER
To: INDIVIOR INC.
Reel/Frame 068796/0364 →
Assignment of Assignor's Interest
Oct 15, 2024
From: CRYSTAL, ROGER; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 068905/0657 →
Security Interest
Nov 13, 2024
From: INDIVIOR INC.; INDIVIOR UK LIMITED
To: PIPER SANDLER FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 069254/0413 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →
Assignment of Assignor's Interest
May 30, 2025
From: AEGIS THERAPEUTICS, LLC
To: INDIVIOR INC.
Reel/Frame 071261/0260 →
Release of Security Interest
Mar 18, 2026
From: PIPER SANDLER FINANCE, LLC
To: INDIVIOR INC.; INDIVIOR UK LIMITED
Reel/Frame 074114/0582 →